Anuncio • 15h
Ventas, Inc. to Report Q2, 2026 Results on Jul 29, 2026 Ventas, Inc. announced that they will report Q2, 2026 results After-Market on Jul 29, 2026 Upcoming Dividend • Jun 24
Upcoming dividend of US$0.52 per share Eligible shareholders must have bought the stock before 30 June 2026. Payment date: 16 July 2026. Trailing yield: 2.4%. Lower than top quartile of Mexican dividend payers (5.8%). Lower than average of industry peers (3.0%). Anuncio • Jun 23
Ventas, Inc. Announces Appointment of Andrew L. Wattula as Executive Vice President, Outpatient Medical & Research, Effective August 2026 Ventas, Inc. announced that the Company had named Andrew L. Wattula Executive Vice President, Outpatient Medical & Research, effective August 2026. He will oversee the Company’s differentiated outpatient medical and research business, which is a leading owner and manager of properties operating at the intersection of medicine, research and universities. He succeeds Peter J. Bulgarelli, who retired from Ventas in May 2026. Wattula brings deep operational, leasing and tenant engagement expertise to Ventas. Working with the Company’s in-place expert teams, Andy will focus on driving operational excellence and maximizing the performance of portfolio. He will report to Debra A. Cafaro, Ventas Chairman and CEO. Wattula is an accomplished commercial real estate leader, with more than twenty years of experience in operations, strategy and leasing. Most recently, he served as Chief Operating Officer at Hudson Pacific Properties, Inc., where he led operations for a 16.5 million square foot office and retail portfolio serving more than 1,000 tenants. Prior to Hudson Pacific, Wattula held roles of increasing responsibility at Beacon Capital Partners and Hines. Before his career in commercial real estate, Wattula served as a Naval Flight Officer in the United States Navy, leading mission-critical teams in operations, training, budgeting and personnel development. Wattula was a mission commander overseas and was awarded the Navy Air Medal for his service. Wattula holds a Bachelor of Science with honors from Vanderbilt University and a Master in Business Administration from Harvard Business School. He serves on the Leadership Council of the Cystic Fibrosis Foundation and is actively engaged with health systems, researchers and donors on pediatric pulmonary research and care. Anuncio • Jun 16
Ventas, Inc. Announces Executive Changes, Effective June 26, 2026 Ventas, Inc. announced that on June 15, 2026, Carey S. Roberts, Executive Vice President, General Counsel, Ethics & Compliance Officer and Corporate Secretary, notified Ventas of her intention to resign from the Company effective June 26, 2026. Ms. Roberts intends to join Blackstone, Inc. as Senior Managing Director and General Counsel - Real Estate. She will remain in her role through the effective date. As of the effective date, Kevin M. Bohl will assume the responsibilities of General Counsel, Ethics & Compliance Officer and Corporate Secretary on an interim basis. Mr. Bohl currently serves as Senior Vice President, Deputy General Counsel and Assistant Corporate Secretary for Ventas and has been with the Company since 2011. Anuncio • Jun 14
Ventas, Inc. (NYSE:VTR) acquired The Aston Gardens at Parkland Commons Senior Living Facility in Broward County from Kayne Anderson Capital Advisors, L.P. for $63.8 million. Ventas, Inc. (NYSE:VTR) acquired The Aston Gardens at Parkland Commons Senior Living Facility in Broward County from Kayne Anderson Capital Advisors, L.P. for $63.8 million on June 12, 2026. Ventas assumed Kayne Anderson Capital Advisors' $39.25 million mortgage with Citibank, representing a commercial mortgage-backed securities (CMBS) trust.
Ventas, Inc. (NYSE:VTR) completed the acquisition of The Aston Gardens at Parkland Commons Senior Living Facility in Broward County from Kayne Anderson Capital Advisors, L.P. on June 12, 2026. Recent Insider Transactions • Jun 06
Independent Director recently bought Mex$3.4m worth of stock On the 3rd of June, Michael Embler bought around 3k shares on-market at roughly Mex$1,364 per share. This transaction increased Michael's direct individual holding by 4x at the time of the trade. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold Mex$50m more in shares than they bought in the last 12 months. Recent Insider Transactions • May 19
Independent Director recently sold Mex$1.8m worth of stock On the 14th of May, Walter Rakowich sold around 1k shares on-market at roughly Mex$1,553 per share. This transaction amounted to 4.2% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of Mex$83m more than they bought in the last 12 months. Declared Dividend • May 19
First quarter dividend of US$0.52 announced Shareholders will receive a dividend of US$0.52. Ex-date: 30th June 2026 Payment date: 16th July 2026 Dividend yield will be 1.8%, which is lower than the industry average of 3.1%. Anuncio • May 14
Ventas, Inc. Declares Quarterly Dividend, Payable on July 16, 2026 Ventas, Inc. announced that its Board of Directors has declared a quarterly dividend of $0.52 per common share. The dividend will be payable in cash on July 16, 2026, to stockholders of record as of the close of business on June 30, 2026. Anuncio • Apr 29
Ventas, Inc. Increases Earnings Guidance for the Full Year 2026 Ventas, Inc. increased earnings guidance for the full year 2026. For the year, the company now expects Attributable Net Income Per Share Range of $0.56 to $0.63 against previous range of $0.52 to $0.62 and Attributable Net Income Per Share Midpoint of $0.60 against previous guidance of $0.57. The increase in the Company’s guidance is primarily the result of higher property performance led by SHOP and accretion from investment activity, partially offset by the market expectation of higher interest rates. Net income attributable to common stockholders to be in the range of $282 million to $317 million against previous range of $260 million to $310 million. Reported Earnings • Apr 29
First quarter 2026 earnings released: FFO per share: US$0.9 (vs US$0.90 in 1Q 2025) First quarter 2026 results: FFO per share: US$0.9 (up from US$0.90 in 1Q 2025). Revenue: US$1.65b (up 22% from 1Q 2025). Funds from operations (FFO): US$439.6m (up 16% from 1Q 2025). FFO margin: 27% (down from 28% in 1Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Global Health Care REITs industry. Anuncio • Apr 03
Ventas, Inc. to Report Q1, 2026 Results on Apr 27, 2026 Ventas, Inc. announced that they will report Q1, 2026 results After-Market on Apr 27, 2026 Anuncio • Apr 02
Ventas, Inc., Annual General Meeting, May 13, 2026 Ventas, Inc., Annual General Meeting, May 13, 2026. Anuncio • Feb 21
Ventas, Inc. Announces Resignation of Gregory R. Liebbe as Senior Vice President, Chief Accounting Officer and Controller, Effective February 27, 2026 On February 16, 2026, announced that Gregory R. Liebbe, Senior Vice President, Chief Accounting Officer and Controller, informed Ventas, Inc. (company) that he is resigning to pursue other opportunities. Mr. Liebbe's last day of employment with the company will be February 27, 2026. Mr. Liebbe's decision to resign is not the result of any disagreement with the company, including with respect to any matter relating to the company's accounting practices or financial reporting. Concurrent with Mr. Liebbe’s departure, Mr. Probst will assume the responsibilities of Chief Accounting Officer on an interim basis while the Company conducts a comprehensive search for a permanent successor. Anuncio • Jan 15
Ventas, Inc. to Report Q4, 2025 Results on Feb 05, 2026 Ventas, Inc. announced that they will report Q4, 2025 results After-Market on Feb 05, 2026 Anuncio • Dec 11
Ventas, Inc. Declares Quarterly Dividend, Payable on January 15, 2026 Ventas, Inc. announced that its Board of Directors has declared a quarterly dividend of $0.48 per common share. The dividend will be payable in cash on January 15, 2026, to stockholders of record as of the close of business on December 31, 2025. Anuncio • Nov 18
Ventas, Inc. Announces Retirement of Peter J. Bulgarelli, Evp, Outpatient Medical & Research, Effective May 1, 2026 Ventas, Inc. announced that Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research has informed the Company of his intention to retire on May 1, 2026. Ventas will commence a search process to identify a successor. Bulgarelli oversees Ventas’s Outpatient Medical & Research and Triple-Net Leased Healthcare businesses and its wholly-owned property management and leasing subsidiary, Lillibridge Healthcare Services. He joined Ventas in 2018 following a twenty-eight-year career at Jones Lang LaSalle, where he led the real estate firm’s healthcare, life sciences, higher education and public sector businesses. Anuncio • Oct 30
Ventas, Inc. Increases Earnings Guidance for the Full Year 2025 Ventas, Inc. increased earnings guidance for the full year 2025. For the year, the company now expects attributable Net Income Per Share in the range of $0.49 - $0.52 compared to previous guidance range of $0.47 - $0.52. Anuncio • Oct 07
Ventas, Inc. to Report Q3, 2025 Results on Oct 29, 2025 Ventas, Inc. announced that they will report Q3, 2025 results After-Market on Oct 29, 2025 Anuncio • Sep 19
Ventas Declares Quarterly Dividend, Payable on October 16, 2025 Ventas, Inc. announced that its Board of Directors has declared a quarterly dividend of $0.48 per common share. The dividend will be payable in cash on October 16, 2025, to stockholders of record as of the close of business on September 30, 2025. Anuncio • Jul 31
Ventas, Inc. Revises Earnings Guidance for the Year 2025 Ventas, Inc. revised earnings guidance for the year 2025. For the year, the company revised the Attributable Net Income Per Share Range of $0.47 - $0.52 per share compared to previous guidance of $0.43 - $0.53 per share a year ago. Anuncio • Jul 08
Ventas, Inc. to Report Q2, 2025 Results on Jul 30, 2025 Ventas, Inc. announced that they will report Q2, 2025 results After-Market on Jul 30, 2025 Anuncio • May 14
Ventas, Inc. Declares Quarterly Cash Dividend, Payable on July 17, 2025 Ventas, Inc. announced that its Board of Directors has declared a quarterly dividend of $0.48 per common share. The dividend will be payable in cash on July 17, 2025 to stockholders of record as of the close of business on June 30, 2025. Anuncio • May 01
Ventas, Inc. Reaffirms Earnings Guidance for the Full Year 2025 Ventas, Inc. reaffirmed earnings guidance for the full year 2025. For the year, the company expects Attributable Net Income Per Share Range in the range of $0.42 - $0.53. Anuncio • Apr 05
Ventas, Inc. to Report Q1, 2025 Results on Apr 30, 2025 Ventas, Inc. announced that they will report Q1, 2025 results After-Market on Apr 30, 2025 Anuncio • Mar 20
Ventas, Inc., Annual General Meeting, May 13, 2025 Ventas, Inc., Annual General Meeting, May 13, 2025. Declared Dividend • Mar 14
Fourth quarter dividend of US$0.48 announced Shareholders will receive a dividend of US$0.48. Ex-date: 31st March 2025 Payment date: 17th April 2025 Dividend yield will be 2.0%, which is lower than the industry average of 3.1%. Anuncio • Jan 17
Ventas, Inc. to Report Q4, 2024 Results on Feb 12, 2025 Ventas, Inc. announced that they will report Q4, 2024 results After-Market on Feb 12, 2025 Anuncio • Dec 11
Ventas Declares Fourth Quarter 2024 Dividend, Payable in Cash on January 16, 2025 Ventas, Inc. announced that its Board of Directors has declared a quarterly dividend of $0.45 per common share. The dividend will be payable in cash on January 16, 2025 to stockholders of record as of the close of business on December 31, 2024. Reported Earnings • Nov 04
Third quarter 2024 earnings released: FFO per share: US$0.8 (vs US$0.74 in 3Q 2023) Third quarter 2024 results: FFO per share: US$0.8 (up from US$0.74 in 3Q 2023). Revenue: US$1.23b (up 7.9% from 3Q 2023). Funds from operations (FFO): US$331.5m (up 12% from 3Q 2023). FFO margin: 27% (up from 26% in 3Q 2023). Revenue is forecast to grow 6.6% p.a. on average during the next 3 years, compared to a 7.2% growth forecast for the Global Health Care REITs industry. Anuncio • Nov 02
Ventas, Inc. Revises Earnings Guidance for the Year 2024 Ventas, Inc. revised earnings guidance for the year 2024. For the year, the company expects net income attributable to common stockholders to be in the range of $0.09 to $0.13 compared to previous guidance of $0.07 to $0.13. Anuncio • Oct 05
Ventas, Inc. to Report Q3, 2024 Results on Oct 30, 2024 Ventas, Inc. announced that they will report Q3, 2024 results After-Market on Oct 30, 2024 Declared Dividend • Sep 21
Second quarter dividend of US$0.45 announced Shareholders will receive a dividend of US$0.45. Ex-date: 1st October 2024 Payment date: 17th October 2024 Dividend yield will be 2.0%, which is lower than the industry average of 3.1%. Anuncio • Sep 19
Ventas, Inc. has filed a Follow-on Equity Offering in the amount of $2 billion. Ventas, Inc. has filed a Follow-on Equity Offering in the amount of $2 billion.
Security Name: Common Stock
Security Type: Common Stock
Security Features: Income Trust
Transaction Features: At the Market Offering Anuncio • Sep 18
Ventas, Inc. Declares Third Quarter 2024 Dividend, Payable on October 17, 2024 Ventas, Inc. announced that its Board of Directors has declared a quarterly dividend of $0.45 per common share. The dividend will be payable in cash on October 17, 2024 to stockholders of record as of the close of business on October 1, 2024. Anuncio • Sep 17
Ventas, Inc. (NYSE:VTR) acquired Five performing LTAC assets for approximately $190 million. Ventas, Inc. (NYSE:VTR) acquired Five performing LTAC assets for approximately $190 million on September 16, 2024.
Ventas, Inc. (NYSE:VTR) completed the acquisition of Five performing LTAC assets on September 16, 2024. New Risk • Sep 17
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.6% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Shares are highly illiquid. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Shareholders have been diluted in the past year (2.6% increase in shares outstanding). Significant insider selling over the past 3 months (Mex$23m sold). New Risk • Sep 10
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.6% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Shares are highly illiquid. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Shareholders have been diluted in the past year (2.6% increase in shares outstanding). Significant insider selling over the past 3 months (Mex$23m sold). Anuncio • Aug 02
Ventas, Inc. Updates Earnings Guidance for the Full Year 2024 Ventas, Inc. updated earnings guidance for the full year 2024. For the year, the company expected attributable net income per share in the range of $0.07 to $0.13 as compared to previous range guidance range of $0.03 to $0.11 and attributable net income per share midpoint of $0.10 as compared to previous range guidance range of $0.07. Declared Dividend • Jun 21
First quarter dividend of US$0.45 announced Shareholders will receive a dividend of US$0.45. Ex-date: 1st July 2024 Payment date: 18th July 2024 Dividend yield will be 2.5%, which is lower than the industry average of 3.1%. Anuncio • May 16
Ventas, Inc. Declares Second Quarter 2024 Dividend, Payable on July 18, 2024 Ventas, Inc. announced that its Board of Directors has declared a quarterly dividend of $0.45 per common share. The dividend will be payable in cash on July 18, 2024 to stockholders of record as of the close of business on July 1, 2024. Anuncio • May 03
Ventas, Inc. Updates Earnings Guidance for the Full Year 2024 Ventas, Inc. updated earnings guidance for the full year 2024. For the year, the company expected attributable net income per share in the range of $0.03 to $0.11 as compared to previous range guidance range of $0.00 to $0.11 and attributable net income per share midpoint of $0.07 as compared to previous range guidance range of $0.06. Anuncio • Apr 04
Ventas, Inc. to Report Q1, 2024 Results on May 01, 2024 Ventas, Inc. announced that they will report Q1, 2024 results After-Market on May 01, 2024 Anuncio • Mar 13
Ventas, Inc. Declares First Quarter 2024 Dividend, Payable on April 18, 2024 Ventas, Inc. announced that its Board of Directors has declared a quarterly dividend of $0.45 per common share. The dividend will be payable in cash on April 18, 2024 to stockholders of record as of the close of business on April 1, 2024. Anuncio • Feb 15
Ventas, Inc. Provides Earnings Guidance for the Year 2024 Ventas, Inc. provided earnings guidance for the year 2024. For the year, the company expects net income attributable to common stockholders to be in the range of USD 0 to USD 47 million or USD 0.11 per share. Anuncio • Jan 24
Ventas, Inc. to Report Q4, 2023 Results on Feb 14, 2024 Ventas, Inc. announced that they will report Q4, 2023 results After-Market on Feb 14, 2024 Anuncio • Dec 06
Ventas Declares Dividend for the Fourth Quarter 2023, Payable on January 18, 2024 Ventas, Inc. announced that its Board of Directors has declared a quarterly dividend of $0.45 per common share. The dividend will be payable in cash on January 18, 2024 to stockholders of record as of the close of business on January 2, 2024. Anuncio • Nov 04
Ventas, Inc. Revises Earnings Guidance for the Year 2023 Ventas, Inc. revised earnings guidance for the year 2023. The company now expects attributable Net Income Per Share Range to be $0.14 - $0.17 against previous guidance of $0.22 - $0.32. Anuncio • Oct 19
Ventas, Inc. to Report Q3, 2023 Results on Nov 02, 2023 Ventas, Inc. announced that they will report Q3, 2023 results After-Market on Nov 02, 2023 Anuncio • Sep 14
Ventas, Inc. Declares Third Quarter 2023 Dividend, Payable in Cash on October 12, 2023 Ventas, Inc. announced that its Board of Directors has declared a quarterly dividend of $0.45 per common share. The dividend will be payable in cash on October 12, 2023 to stockholders of record as of the close of business on October 2, 2023. Anuncio • Sep 12
Land & Buildings Investment Management Sends Letter to Shareholders of Ventas On September 11, 2023, Land & Buildings Investment Management LLC announced that it has sent a letter to shareholders of Ventas Inc, stating that the fundamentals of senior housing are strengthening across multiple key pillars with accelerating demographic-driven needs-based demand, declining new competitive supply growth and waning expense headwinds, yet the Company has generated a negative total return year-to-date, underperforming Welltower by 33%, and despite the continued senior housing strength and recovery, Company has failed to outperform the Healthcare REIT Index. In addition, Land & Buildings Investment Management stated that it believes meaningful board change is necessary to restore accountability and maximize value for all stakeholders, despite its continued disappointment with management and the board, it remains open to continuing dialogue with the Company regarding opportunities to restore accountability and proper governance, improve performance and drive shareholder value for the benefit of all the Company stakeholders. Anuncio • Jul 22
Ventas, Inc. to Report Q2, 2023 Results on Aug 03, 2023 Ventas, Inc. announced that they will report Q2, 2023 results After-Market on Aug 03, 2023 Anuncio • May 17
Ventas, Inc. Declares Second Quarter 2023 Dividend, Payable on July 13, 2023 Ventas, Inc. announced that its Board of Directors has declared a quarterly dividend of $0.45 per common share. The dividend will be payable in cash on July 13, 2023 to stockholders of record as of the close of business on July 3, 2023. Anuncio • May 09
Ventas, Inc. Provides Earnings Guidance for the Full Year 2023 Ventas, Inc. provided earnings guidance for the full year 2023. For the year, the company expects attributable net income per share to be between $0.20 to $0.34 and attributable Net Income Per Share Midpoint of $0.27. Reported Earnings • Feb 11
Full year 2022 earnings released: FFO per share: US$2.8 (vs US$2.67 in FY 2021) Full year 2022 results: FFO per share: US$2.8 (up from US$2.67 in FY 2021). Funds from operations (FFO): US$1.14b (up 11% from FY 2021). Revenue is forecast to grow 82% p.a. on average during the next 2 years, compared to a 6.8% growth forecast for the REITs industry in Mexico. Anuncio • Feb 10
Ventas, Inc. Provides Earnings Guidance for the Year 2023 Ventas, Inc. provided earnings guidance for the year 2023. For the year, the company expects attributable net income per share to be between $0.20 to $0.34. Anuncio • Jan 24
Ventas, Inc. Appoints J. Justin Hutchens, Executive Vice President, Senior Housing, to Additional Role of Chief Investment Officer Ventas, Inc. announced that J. Justin Hutchens, Executive Vice President, Senior Housing, has been appointed to the additional role of Chief Investment Officer, effective immediately. In his expanded role, Hutchens will be responsible for Ventas’s capital allocation strategy and execution across the enterprise in addition to his current responsibility for the Company’s Senior Housing portfolio. He will oversee both the Senior Housing and Investments teams and continue to report directly to Ventas Chairman and CEO Debra A. Cafaro. With more than 25 years of experience in both REITs and senior housing, Hutchens has significant investment and capital allocation expertise and a record of proven success. He has led Ventas’s Senior Housing business since joining the Company in early 2020, with responsibility for more than 800 communities representing nearly half of the Company’s portfolio. Hutchens previously served as President and Chief Investment Officer of HCP and Chief Executive Officer and President of National Health Investors. Hutchens joined Ventas from HC-One, the UK’s care homes operator with over 325 locations and over 22,000 employees, where he served as Chief Executive Officer from 2017 to 2020. Hutchens will assume the responsibilities of John D. Cobb, who will be leaving the Company. Cobb has agreed to remain at the Company as a strategic advisor through mid-February. Anuncio • Jan 19
Ventas, Inc. to Report Q4, 2022 Results on Feb 09, 2023 Ventas, Inc. announced that they will report Q4, 2022 results at 4:00 PM, US Eastern Standard Time on Feb 09, 2023 Upcoming Dividend • Dec 23
Upcoming dividend of US$0.45 per share Eligible shareholders must have bought the stock before 30 December 2022. Payment date: 19 January 2023. Trailing yield: 4.0%. Lower than top quartile of Mexican dividend payers (6.4%). Lower than average of industry peers (6.1%). Reported Earnings • Nov 04
Third quarter 2022 earnings released: FFO per share: US$0.8 (vs US$0.59 in 3Q 2021) Third quarter 2022 results: FFO per share: US$0.8 (up from US$0.59 in 3Q 2021). Funds from operations (FFO): US$304.2m (up 36% from 3Q 2021). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 3.0% growth forecast for the REITs industry in Mexico. Reported Earnings • Aug 05
Second quarter 2022 earnings released: FFO per share: US$0.6 (vs US$0.79 in 2Q 2021) Second quarter 2022 results: FFO per share: US$0.6 (down from US$0.79 in 2Q 2021). Revenue: US$1.02b (up 11% from 2Q 2021). Funds from operations (FFO): US$242.9m (down 18% from 2Q 2021). FFO margin: 24% (down from 32% in 2Q 2021). Over the next year, revenue is forecast to grow 7.4%, compared to a 12% growth forecast for the industry in Mexico. Upcoming Dividend • Jun 23
Upcoming dividend of US$0.45 per share Eligible shareholders must have bought the stock before 30 June 2022. Payment date: 14 July 2022. Trailing yield: 3.6%. Lower than top quartile of Mexican dividend payers (5.8%). Lower than average of industry peers (5.6%).